Medicaid

Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in...

Hospital Information Systems Market worth US$116.75 billion by 2030 with 10.6% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., March 21, 2025 /PRNewswire/ -- The global Hospital Information Systems Market, valued at US$58.13 billion in 2023, is...

error: Content is protected !!